Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Renren Inc., China's biggest networking website by page views, is discussed by Yoshikami with Emily Chang and Cory Johnson on 'Bloomberg West'.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Joseph Chen and Chen Ji are the CEOs of Renren
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Advancements in Distributed Acoustic Sensing for Landslide Monitoring
00:10:00
Ryan Long Discusses Copper Fox Metals' Strategy and Key Assets with Katie
00:10:00
Observit AB CEO Björn Callenfors Discusses Strategy and Vision Ahead of IPO | Björn Callenfor, CEO, Observit AB.
00:10:00
Neil Woodyer CEO of Aris Mining in an interview | Neil Woodyer, CEO and Director, Aris Mining Corporation (IE)
00:10:00
Tri-K Gold: Driving Growth in West African Gold Production
00:10:00
Clean Well Announces Share Buyback Program Amid Strong Financial Performance and Promising Pipeline Prospects | Dr Philippe Wolgen, CEO, Clinuvel Pharmaceuticals Ltd.
00:10:00
Unlocking Revenue and Digital Success: Shueisha's Cxense Strategy Revealed! | Christian Printzell Halvorsen, CEO, Cxense ASACXENSE:OSL
00:10:00
Insights on Lease Flexibility, Inflation Impact, and Growth Opportunities in Logistics and Data Centers | Simon Garing, CEO, Cromwell European Real Estate Investment Trust.
00:10:00
Fram Skandinavien AB's Virtual Capital Markets Day 2020: Q&A Highlights | Per Rundblom , CEO of Fram Skandinavien AB
00:10:00
Maximizing the Value of Volunteer Time in Social Enterprises
00:10:00
Aegon CEO Discusses Commercial Momentum and Risk Management Amid Market Volatility | Lard Friese, CEO , Aegon N.V.
00:10:00
The Future of Lending: Democratizing Finance with Rob Frohwein, CEO of Kabbage, and Charlie Wells, Wall Street Journal